We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Improved Survival with Immunotherapy but Lack of Synergistic Effect with Radiation for Stage IV Melanoma of the Head and Neck.
- Authors
BABCOCK, BLAKE; RODRIGUES, MEDORA; KEARNS, DONOVAN; SOLOMON, NAVEENRAJ; REEVES, MARK E.; SENTHIL, MAHESWARI; GARBEROGLIO, CARLOS A.; NAMM, JUKES P.
- Abstract
Prospective randomized studies have demonstrated a survival benefit of immunotherapy in stage IV cutaneous melanoma. Some retrospective studies have hypothesized a synergistic effect of radiation and immunotherapy. Our objective was to identify whether there is a survival benefit for patients treated with radiation and immunotherapy in stage IV cutaneous melanoma of the head and neck (CMHN). The National Cancer Database was used to identify patients with stage IV CMHN between 2012 and 2014. These patients were stratified based on receipt of radiation and immunotherapy. Adjusted Cox regression was used to analyze overall survival. A total of 542 patients were identified with stage IV CMHN, of whom 153 (28%) patients received immunotherapy. Receipt of immunotherapy (hazard ratio [HR] 0.69, P = 0.02) and negative LNs (HR 0.50, P = 0.002) were independently associated with improved survival, whereas radiation conferred no survival benefit (HR 1.17, P = 0.26). Patients who received immunotherapy without radiation were associated with significantly improved survival compared with those who received immunotherapy with radiation (P < 0.0001). However, of patients who received radiation, the addition of immunotherapy did not seem to improve survival (P = 0.979). In stage IV CMHN, immunotherapy confers a 32 per cent survival benefit. The use of immunotherapy in patients who require radiation, however, is not associated with improved survival.
- Subjects
IMMUNOTHERAPY; MELANOMA; RADIATION; NECK
- Publication
American Surgeon, 2019, Vol 85, Issue 10, p1118
- ISSN
0003-1348
- Publication type
journal article
- DOI
10.1177/000313481908501009